FDA OKs Istradefylline for Parkinson ' s Disease ' Off ' Episodes FDA OKs Istradefylline for Parkinson ' s Disease ' Off ' Episodes
Oral istradefylline (Nourianz) reduces"off" episodes when added to levodopa/carbidopa in patients with Parkinson ' s disease.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Alert Source Type: news
More News: Brain | Carbidopa/Levodopa | Drugs & Pharmacology | Neurology | Neurosurgery | Parkinson's Disease